UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?
This recovery story is turning into a success story.
Overview
Last year, UnitedHealth Group's (NYSE: UNH) struggles with rising medical costs weighed significantly on earnings -- and on stock performance. But the company has since put into place a plan to turn things around, and that plan has been bearing fruit. Though UnitedHealth's challenges haven't disappeared, the company is better navigating the current market, and efforts are paving the way for long-term growth.
Earnings in the recent quarter, which surpassed estimates, confirmed this positive momentum. And investors haven't ignored this important turnaround story. They've piled into UnitedHealth shares, sending the stock to a 21% gain so far this year. Considering this market-beating performance, is the stock still a buy? Let's find out.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.